Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer.

The International journal of biological markers - 23 Apr 2013

Ziaei Seyed Amir Mohsen, Samzadeh Mohammad, Jamaldini Seyed Hamid, Afshari Mahdi, Haghdoost Ali Akbar, Hasanzad Mandana

Abstract excerpt

BACKGROUND: The endothelial form of nitric oxide synthases (eNOS) seems to have an important role in vascular development, maintenance of the vascular tone and tumor growth in human prostate cancer (PC). The purpose of this study was to investigate the association between grade and stage of disease, age of diagnosis, vascular or perineural invasion, pre-diagnostic plasma prostate-specific antigen (PSA) levels,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Association Studies

Share to Neoplasm Invasiveness

Share to Nitric Oxide Synthase Type III

Share to Odds Ratio

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 23015399
DOI: 10.5301/JBM.2012.9585

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer.PMID 23015399Read ↗

The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.Semantic proximity Read ↗

Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer.Semantic proximity Read ↗

Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7.Semantic proximity Read ↗

Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Susceptibility to Prostate Cancer: a Comprehensive Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Association of endothelia nitric oxide synthase gene rs1799983 polymorphism with susceptibility to prostate cancer: a meta-analysis.Semantic proximity Read ↗

Association between endothelial nitric oxide synthase 894G>T polymorphism and prostate cancer risk: a meta-analysis of literature studies.Semantic proximity Read ↗

Genetic variants within endothelial nitric oxide synthase gene and prostate cancer: a meta-analysis.Semantic proximity Read ↗

Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population.Semantic proximity Read ↗

Investigation of the relationships between eNOS T786C, G894T, intron 4 VNTR (4a/b) gene variations and prostate cancer development and progression.Semantic proximity Read ↗

The T -786C, G894T, and Intron 4 VNTR (4a/b) Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Prostate Cancer Cases.Semantic proximity Read ↗

Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis.Semantic proximity Read ↗

The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.